Elcomscience

Elcomscience is a South Korean biotechnology company specializing in the development of drug delivery systems designed to cross the blood-brain barrier (BBB). The company's proprietary Elcom-Trans platform utilizes a peptide-based shuttle system to deliver various therapeutic modalities, including small molecules and antibodies, into the central nervous system. Their current research and development efforts are focused on high-unmet-need areas such as Alzheimer's disease, Parkinson's disease, and malignant brain tumors. By improving the bioavailability of drugs in the brain, Elcomscience seeks to transform the treatment landscape for neurodegenerative and oncological CNS disorders. The company leverages its expertise in protein engineering and medicinal chemistry to optimize its pipeline of CNS-targeted therapies.